IL314507A - Tragnostic acid pairs - Google Patents

Tragnostic acid pairs

Info

Publication number
IL314507A
IL314507A IL314507A IL31450724A IL314507A IL 314507 A IL314507 A IL 314507A IL 314507 A IL314507 A IL 314507A IL 31450724 A IL31450724 A IL 31450724A IL 314507 A IL314507 A IL 314507A
Authority
IL
Israel
Prior art keywords
theragnostic
folate conjugates
folate
conjugates
theragnostic folate
Prior art date
Application number
IL314507A
Other languages
English (en)
Hebrew (he)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL314507A publication Critical patent/IL314507A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL314507A 2022-02-01 2023-01-30 Tragnostic acid pairs IL314507A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22154653 2022-02-01
PCT/EP2023/052116 WO2023148115A1 (en) 2022-02-01 2023-01-30 Theragnostic folate conjugates

Publications (1)

Publication Number Publication Date
IL314507A true IL314507A (en) 2024-09-01

Family

ID=80119142

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314507A IL314507A (en) 2022-02-01 2023-01-30 Tragnostic acid pairs

Country Status (9)

Country Link
US (1) US20250108138A1 (cg-RX-API-DMAC7.html)
EP (1) EP4472676A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025504028A (cg-RX-API-DMAC7.html)
KR (1) KR20240142514A (cg-RX-API-DMAC7.html)
CN (1) CN118660723A (cg-RX-API-DMAC7.html)
AU (1) AU2023214599A1 (cg-RX-API-DMAC7.html)
CA (1) CA3243526A1 (cg-RX-API-DMAC7.html)
IL (1) IL314507A (cg-RX-API-DMAC7.html)
WO (1) WO2023148115A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025220711A1 (ja) * 2024-04-17 2025-10-23 日本メジフィジックス株式会社 化合物、放射性標識化合物及びその製造方法、並びに放射性医薬組成物
WO2026014283A1 (ja) * 2024-07-09 2026-01-15 日本メジフィジックス株式会社 化合物、放射性標識化合物およびその製造方法、並びに放射性医薬組成物

Also Published As

Publication number Publication date
CN118660723A (zh) 2024-09-17
AU2023214599A1 (en) 2024-09-19
CA3243526A1 (en) 2023-08-10
EP4472676A1 (en) 2024-12-11
US20250108138A1 (en) 2025-04-03
JP2025504028A (ja) 2025-02-06
WO2023148115A1 (en) 2023-08-10
KR20240142514A (ko) 2024-09-30

Similar Documents

Publication Publication Date Title
IL315508A (en) Camptothecin conjugates
IL308811A (en) NEODEGRADER clamps
IL278990A (en) Captures of camptothecin
EP4126068A4 (en) CONJUGATES
PT3946464T (pt) Compostos e seus conjugados
IL318188A (en) Antibody-drug conjugates
IL291486B1 (en) Therapeutic conjugates
IL308812A (en) NEODEGRADER-ANTI-CD33 ANTIBODY conjugates
GB202118938D0 (en) Conjugate
IL318450A (en) Immunostimulatory ANTI-PD-L1-Drug conjugates
GB2594753B (en) Antibody-drug conjugates
GB201820864D0 (en) Antibody-drug conjugates
IL319822A (en) New joint material couplings
EP4203968A4 (en) DENDRIMER-DRUG CONJUGATE
IL288681A (en) Pyrrolobenzodiazepine-antibody conjugates
GB202210058D0 (en) Conjugates
GB201906997D0 (en) Conjugates
GB202105186D0 (en) Pyrrolobenzodiazepine conjugates
GB202105187D0 (en) Pyrrolobenzodiazepine conjugates
IL307947A (en) An antiviral compound of proteins
GB202509672D0 (en) Conjugates
GB202502258D0 (en) Conjugates
HK40111883A (en) Lectin-drug conjugates
GB202414843D0 (en) Conjugates
GB202409736D0 (en) conjugates